Monkhouse et al., 1972 - Google Patents
Use of adsorbents in enhancement of drug dissolution IMonkhouse et al., 1972
- Document ID
- 12546076963003582415
- Author
- Monkhouse D
- Lach J
- Publication year
- Publication venue
- Journal of pharmaceutical sciences
External Links
Snippet
A new approach is described for increasing the dissolution rates of relatively insoluble powders. It is based on the concept of increasing the surface available for contact with dissolution media. This is accomplished by equilibration of the drug in an organic solvent …
- 239000003814 drug 0 title abstract description 97
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/02—Inorganic compounds
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Monkhouse et al. | Use of adsorbents in enhancement of drug dissolution I | |
| EP0069097B1 (en) | Pharmaceutical mixture | |
| Alsaidan et al. | Improved dissolution rate of indomethacin by adsorbents | |
| US4847077A (en) | Controlled release pharmaceutical preparations | |
| KR100209175B1 (en) | Pharmaceutical composition for rapid suspension in water | |
| US4221778A (en) | Prolonged release pharmaceutical preparations | |
| US4959219A (en) | Coating barriers comprising ethyl cellulose | |
| US3629392A (en) | Entrapment compositions and processes | |
| Junyaprasert et al. | Release profile comparison and stability of diltiazem–resin microcapsules in sustained release suspensions | |
| CA1110166A (en) | Coating ensuring a controlled release of active ingred ients of biologically active compositions, particularl y pharmaceutical compositions and a process for the pr eparation of biologically active compositions ensuring controlled release of active ingredients | |
| DE3218059A1 (en) | A MICROCAPSLE CONTAINING PHARMACEUTICAL ACTIVE SUBSTANCE AND METHOD FOR THE PRODUCTION THEREOF | |
| JPH0764725B2 (en) | Sustained release tablet and method for producing the same | |
| AU2015254874A1 (en) | Extended release liquid compositions of metformin | |
| JPS6335527A (en) | Coated ion exchange resin | |
| Lorenzo-Lamosam et al. | Development of a microencapsulated form of cefuroxime axetil using pH-sensitive acrylic polymers | |
| US5532305A (en) | Controlled release preparation for bioactive substances | |
| US3584113A (en) | Process for the production of medical preparations having sustained release of therapeutical effect | |
| JPH0813736B2 (en) | Method for preparing tablets or dragee compositions containing heat-, light-, and moisture-sensitive active ingredients having a monoclinic crystal structure | |
| JP2849047B2 (en) | Diclofenac sodium sustained-release preparation and its production method | |
| CA1283497C (en) | Polymer-treated ion exchange resins | |
| US4834982A (en) | Potassium-neutral salureticum with anti-hypertensive effect | |
| KR910003557B1 (en) | Process for preparing liquid prolonged release pharmaceutical formulations | |
| Lheritier et al. | Improvement of the dissolution kinetics of SR 33557 by means of solid dispersions containing PEG 6000 | |
| Cakiryildiz et al. | Dissolution studies with a multichannel continuous‐flow apparatus | |
| USRE28316E (en) | Entrapment compositions and processes |